Bernhard Volz

Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

Alexander Hein, Andreas D. Hartkopf, Julius Emons et al. · European Journal of Cancer · 2021 · 84 citations

Oncology, Pathology, Breast Cancer +5

Mutations in <i>BRCA1/2</i> and Other Panel Genes in Patients With Metastatic Breast Cancer —Association With Patient and Disease Characteristics and Effect on Prognosis

Peter A. Fasching, Siddhartha Yadav, Chunling Hu et al. · Journal of Clinical Oncology · 2021 · 75 citations · Full text

Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

Volkmar Müller, Naiba Nabieva, Lothar Häberle et al. · The Breast · 2017 · 62 citations

Nursing, Quality Of Life, Metastatic Breast Cancer +9

Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry

Andreas D. Hartkopf, Jens Huober, Bernhard Volz et al. · The Breast · 2017 · 57 citations

Breast Oncology, Treatment Landscape, Medicine +6

Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

Andreas Schneeweiß, Johannes Ettl, Diana Lüftner et al. · The Breast · 2020 · 54 citations · Full text